US Bancorp DE Sells 1,978 Shares of ICU Medical, Incorporated (ICUI)

US Bancorp DE reduced its holdings in ICU Medical, Incorporated (NASDAQ:ICUI) by 14.3% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 11,821 shares of the medical instruments supplier’s stock after selling 1,978 shares during the quarter. US Bancorp DE’s holdings in ICU Medical were worth $2,554,000 as of its most recent filing with the SEC.

Several other institutional investors have also bought and sold shares of ICUI. California Public Employees Retirement System lifted its position in shares of ICU Medical by 8.1% in the 2nd quarter. California Public Employees Retirement System now owns 26,800 shares of the medical instruments supplier’s stock worth $4,623,000 after buying an additional 2,000 shares during the last quarter. Parametric Portfolio Associates LLC lifted its position in shares of ICU Medical by 11.1% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 29,688 shares of the medical instruments supplier’s stock worth $5,121,000 after buying an additional 2,973 shares during the last quarter. Voya Investment Management LLC lifted its position in shares of ICU Medical by 22.8% in the 2nd quarter. Voya Investment Management LLC now owns 7,008 shares of the medical instruments supplier’s stock worth $1,209,000 after buying an additional 1,303 shares during the last quarter. State Street Corp lifted its position in shares of ICU Medical by 5.1% in the 2nd quarter. State Street Corp now owns 388,207 shares of the medical instruments supplier’s stock worth $66,963,000 after buying an additional 18,895 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership bought a new position in shares of ICU Medical in the 2nd quarter worth about $2,312,000. Institutional investors own 77.82% of the company’s stock.

Separately, Zacks Investment Research upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $266.00 price target on the stock in a research report on Tuesday, January 23rd. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $266.00.

In related news, Director Robert S. Swinney sold 724 shares of ICU Medical stock in a transaction dated Friday, January 19th. The shares were sold at an average price of $235.00, for a total value of $170,140.00. Following the sale, the director now directly owns 14,830 shares in the company, valued at approximately $3,485,050. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CFO Scott E. Lamb sold 23,624 shares of ICU Medical stock in a transaction dated Thursday, January 4th. The shares were sold at an average price of $220.00, for a total transaction of $5,197,280.00. Following the completion of the sale, the chief financial officer now owns 29,723 shares in the company, valued at $6,539,060. The disclosure for this sale can be found here. Over the last quarter, insiders sold 27,348 shares of company stock worth $6,014,640. 13.60% of the stock is currently owned by insiders.

Shares of ICU Medical, Incorporated (ICUI) opened at $226.50 on Thursday. The firm has a market cap of $4,408.59, a PE ratio of 147.08, a P/E/G ratio of 2.31 and a beta of 0.42. ICU Medical, Incorporated has a 52-week low of $142.01 and a 52-week high of $240.20. The company has a debt-to-equity ratio of 0.07, a current ratio of 4.65 and a quick ratio of 3.01.

WARNING: This report was first posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this report on another website, it was stolen and reposted in violation of United States and international copyright & trademark law. The original version of this report can be viewed at https://www.chaffeybreeze.com/2018/02/15/us-bancorp-de-sells-1978-shares-of-icu-medical-incorporated-icui.html.

ICU Medical Profile

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply